Johanna Galaski1, Fareed Ahmad, Nadine Tibroni, Francois M Pujol, Birthe Müller, Reinhold E Schmidt, Oliver T Fackler. 1. *Department of Infectious Diseases, Integrative Virology, University Hospital Heidelberg, Heidelberg, Germany; †German Center for Infection Research, Heidelberg University, Heidelberg, Germany; ‡Department of Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany; and §German Center for Infection Research, Hannover Medical School, Hannover, Germany.
Abstract
OBJECTIVE: HIV-1 Vpu and Nef proteins downregulate cell surface levels of natural killer (NK) cell ligands but functional consequences of individual downregulation events are unclear. We tested how well-conserved NK cell ligand downregulation is among Vpu and Nef variants isolated from chronic HIV patients. METHODS: Proviral vpu and nef sequences were amplified from 27 chronic HIV patients, subcloned, and tested for their ability to downregulate cell surface receptors. RESULTS: Cell surface downregulation of CD4, CD317/tetherin, and major histocompatibility complex class 1 that exert biological functions other than NK cell activation were well conserved among patient-derived Vpu and Nef variants. Among NK cell ligands, NK-T-B-antigen, poliovirus receptor, and UL16-binding protein were identified as main targets for Vpu and Nef, the downregulation of which by at least 1 viral protein was highly conserved. NK cell ligands displayed specific sensitivity to Vpu (NK-T-B-antigen) or Nef (poliovirus receptor), and downregulation of cell surface UL16-binding protein was identified as a novel and highly conserved activity of HIV-1 Vpu but not Nef. CONCLUSIONS: The conservation of downregulation of major NK cell ligands by either HIV-1 Vpu or Nef suggests an important pathophysiological role of this activity, which may impact the acute but not the chronic phase of HIV infection.
OBJECTIVE:HIV-1Vpu and Nef proteins downregulate cell surface levels of natural killer (NK) cell ligands but functional consequences of individual downregulation events are unclear. We tested how well-conserved NK cell ligand downregulation is among Vpu and Nef variants isolated from chronic HIV patients. METHODS: Proviral vpu and nef sequences were amplified from 27 chronic HIV patients, subcloned, and tested for their ability to downregulate cell surface receptors. RESULTS: Cell surface downregulation of CD4, CD317/tetherin, and major histocompatibility complex class 1 that exert biological functions other than NK cell activation were well conserved among patient-derived Vpu and Nef variants. Among NK cell ligands, NK-T-B-antigen, poliovirus receptor, and UL16-binding protein were identified as main targets for Vpu and Nef, the downregulation of which by at least 1 viral protein was highly conserved. NK cell ligands displayed specific sensitivity to Vpu (NK-T-B-antigen) or Nef (poliovirus receptor), and downregulation of cell surface UL16-binding protein was identified as a novel and highly conserved activity of HIV-1Vpu but not Nef. CONCLUSIONS: The conservation of downregulation of major NK cell ligands by either HIV-1Vpu or Nef suggests an important pathophysiological role of this activity, which may impact the acute but not the chronic phase of HIV infection.
Authors: Zachary Ende; Martin J Deymier; Daniel T Claiborne; Jessica L Prince; Daniela C Mónaco; William Kilembe; Susan A Allen; Eric Hunter Journal: J Virol Date: 2018-03-14 Impact factor: 5.103
Authors: François M Pujol; Vibor Laketa; Florian Schmidt; Markus Mukenhirn; Barbara Müller; Steeve Boulant; Dirk Grimm; Oliver T Keppler; Oliver T Fackler Journal: J Virol Date: 2016-07-11 Impact factor: 5.103
Authors: Asa Rahimi; Gursev Anmole; Maribel Soto-Nava; Tania Escamilla-Gomez; Tristan Markle; Steven W Jin; Guinevere Q Lee; P Richard Harrigan; David R Bangsberg; Jeffrey Martin; Santiago Avila-Rios; Gustavo Reyes-Teran; Mark A Brockman; Zabrina L Brumme Journal: J Virol Methods Date: 2016-11-16 Impact factor: 2.014
Authors: Simon Langer; Christian Hammer; Kristina Hopfensperger; Lukas Klein; Dominik Hotter; Paul D De Jesus; Kristina M Herbert; Lars Pache; Nikaïa Smith; Johannes A van der Merwe; Sumit K Chanda; Jacques Fellay; Frank Kirchhoff; Daniel Sauter Journal: Elife Date: 2019-02-05 Impact factor: 8.140
Authors: Zabrina L Brumme; Mark A Brockman; Gisele Umviligihozo; Kyle D Cobarrubias; Sandali Chandrarathna; Steven W Jin; Nicole Reddy; Helen Byakwaga; Conrad Muzoora; Mwebesa B Bwana; Guinevere Q Lee; Peter W Hunt; Jeff N Martin; Chanson J Brumme; David R Bangsberg; Etienne Karita; Susan Allen; Eric Hunter; Thumbi Ndung'u Journal: J Virol Date: 2020-07-01 Impact factor: 5.103